Helicos Eyeing Potential MDx Applications as FY 2009 Revenues Hit $3M

Helicos' revenues for the year increased sharply, though the firm reported revenue from the sales of only two of its single-molecule sequencing systems. It is now considering a repositioning of its strategy, with an eye on the molecular diagnostics market.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories